Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Signet Therapeutics
company
About
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2020
- Operating Status
- Active
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
Signet Therapeutics has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Oct 29, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 29, 2021 | Seed | $10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Signet Therapeutics is funded by 1 investors.
Blue Ocean Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Blue Ocean Capital
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
